On Wednesday, Aileron Therapeutics Inc (NASDAQ; ALRN) revealed topline data from Cohort 2 of its Phase 1b trial of safety and ...

Waltham, Massachusetts Friday, November 15, 2024, 15:00 Hrs [IST] ...

Aileron Therapeutics (ALRN) announced positive topline data from Cohort 2 of its Phase 1b clinical trial evaluating the safety and tolerability ...

Study: Alveolar macrophage function is impaired ... in increased bronchoalveolar lavage fluid (BALF) turbidity and surfactant A post-exposure. Cytokine and chemokine levels in BALF did not ...

In a healthy lung, excess surfactant is cleared and digested by immune cells called alveolar macrophages. Alveolar macrophages need to be stimulated by granulocyte-macrophage colony-stimulating ...

Pulmonary alveolar proteinosis is caused by a buildup in the lungs’ alveoli of a substance called surfactant that’s made up of proteins and lipids. The buildup can block air from moving ...

These cells include alveolar type 2 (AT2) cells, which normally help repair the lungs after injury and secrete surfactant that coats the lungs and is needed for breathing. “We will combine state ...

Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, reported financial results for the third ...

Pulmonary surfactant is a surface-active complex of phospholipids and proteins formed by type II alveolar cells. The proteins and lipids that make up the surfactant have both hydrophilic and ...

In a healthy lung, excess surfactant is cleared and digested by immune cells called alveolar macrophages. Alveolar macrophages need to be stimulated by granulocyte-macrophage colony-stimulating ...